HYBRID TUMOR/CANCER THERAPY BASED ON TARGETING THE RESOLUTION OF OR INDUCING TRANSCRIPTION… Application WO-2023021113-A1 World Intellectual Property Organisation (WIPO) 23 Feb 2023